Targeting RAS guanyl releasing protein 1 promotes T lymphocytes infiltrations and improves anti‐programmed death receptor ligand 1 therapy response of triple‐negative breast cancer

Detalles Bibliográficos
Autores principales: Chen, Xi, Yan, Yuanliang, Liu, Wangrui, Liu, Yuanhong, Thakur, Abhimanyu, Liang, Qiuju, Xu, Zhijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352603/
https://www.ncbi.nlm.nih.gov/pubmed/37461253
http://dx.doi.org/10.1002/ctm2.1335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352603/
https://www.ncbi.nlm.nih.gov/pubmed/37461253
http://dx.doi.org/10.1002/ctm2.1335

Ejemplares similares